Drug intelligence / Profile preview

calcium gluconate + zinc gluconate + lysine hydrochloride

Development stage
Approved
Lead developer
Hubei Wushi Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Calcium gluconate + zinc gluconate + lysine hydrochloride (commonly referred to in China as Glucose Calcium Zinc Oral Solution or 葡萄糖钙锌口服溶液) is an approved oral fixed-dose combination supplement. Developed and manufactured by Hubei Wushi Pharmaceutical (and marketed under brands such as Fuwa), this combination product is formulated as an oral solution. It contains calcium gluconate, zinc gluconate, and lysine hydrochloride as its active ingredients. It is primarily indicated for the treatment and prevention of calcium and zinc deficiencies, supporting bone development, improving appetite, promoting growth, and treating conditions such as rickets, osteomalacia, osteoporosis, growth retardation in children, anorexia, recurrent oral ulcers, and acne.

Brand names
CimuFuwaXingai Jindian慈母扶娃新盖金典
Other names
Calcium and Zinc Gluconates Oral Solutioncalcium gluconate + zinc gluconate + lysinecalcium gluconate + zinc gluconate + lysine hydrochlorideglucose + calcium + zinc葡萄糖酸钙锌口服溶液葡萄糖钙锌口服溶液
02

Targets

CaSR (Extracellular calcium-sensing receptor)

Beyond the preview

Go deeper on calcium gluconate + zinc gluconate + lysine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium gluconate + zinc gluconate + lysine hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call